Interpretation of Incidence Rates Data
Incidence Rate Report by State
Pancreas (Late Stage^), 2016-2020
All Races (includes Hispanic), Female, All Ages
Sorted by Name
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.4 to 8.5 and 18,137 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 72.5
Alabama6
- Rate : The incidence rate is 6.9 with a 95% confidence interval from 6.5 to 7.3 and 241 average annual cases over 2016-2020.
- CI*Rank⋔ : 46 (40, 49)
- Percent of Cases with Late Stage : 61.7
Alaska6
- Rate : The incidence rate is 8.1 with a 95% confidence interval from 6.8 to 9.6 and 30 average annual cases over 2016-2020.
- CI*Rank⋔ : 31 (1, 49)
- Percent of Cases with Late Stage : 70.3
Arizona6
- Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.7 to 7.4 and 350 average annual cases over 2016-2020.
- CI*Rank⋔ : 45 (39, 48)
- Percent of Cases with Late Stage : 67.2
Arkansas6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.2 to 8.3 and 161 average annual cases over 2016-2020.
- CI*Rank⋔ : 39 (23, 47)
- Percent of Cases with Late Stage : 72.0
California3
- Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.9 to 8.2 and 1,946 average annual cases over 2016-2020.
- CI*Rank⋔ : 33 (25, 38)
- Percent of Cases with Late Stage : 74.2
Colorado6
- Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.8 to 7.6 and 245 average annual cases over 2016-2020.
- CI*Rank⋔ : 44 (36, 48)
- Percent of Cases with Late Stage : 71.6
Connecticut3
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.1 to 10.2 and 258 average annual cases over 2016-2020.
- CI*Rank⋔ : 5 (1, 18)
- Percent of Cases with Late Stage : 77.8
Delaware6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 7.6 to 9.6 and 63 average annual cases over 2016-2020.
- CI*Rank⋔ : 26 (1, 44)
- Percent of Cases with Late Stage : 70.0
District of Columbia6
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 8.5 to 11.4 and 38 average annual cases over 2016-2020.
- CI*Rank⋔ : 2 (1, 37)
- Percent of Cases with Late Stage : 69.3
Florida6
- Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.9 to 8.3 and 1,393 average annual cases over 2016-2020.
- CI*Rank⋔ : 32 (25, 39)
- Percent of Cases with Late Stage : 71.7
Georgia3
- Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.9 to 9.5 and 597 average annual cases over 2016-2020.
- CI*Rank⋔ : 7 (3, 22)
- Percent of Cases with Late Stage : 78.4
Hawaii3
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 7.8 to 9.5 and 89 average annual cases over 2016-2020.
- CI*Rank⋔ : 24 (3, 43)
- Percent of Cases with Late Stage : 72.1
Idaho3
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 7.8 to 9.4 and 94 average annual cases over 2016-2020.
- CI*Rank⋔ : 25 (3, 42)
- Percent of Cases with Late Stage : 73.4
Illinois3
- Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.8 to 9.4 and 783 average annual cases over 2016-2020.
- CI*Rank⋔ : 9 (5, 23)
- Percent of Cases with Late Stage : 73.3
Iowa3
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.3 to 9.4 and 198 average annual cases over 2016-2020.
- CI*Rank⋔ : 18 (4, 35)
- Percent of Cases with Late Stage : 76.3
Kansas6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.3 to 8.4 and 151 average annual cases over 2016-2020.
- CI*Rank⋔ : 37 (20, 46)
- Percent of Cases with Late Stage : 76.5
Kentucky3
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.4 to 9.3 and 272 average annual cases over 2016-2020.
- CI*Rank⋔ : 17 (5, 31)
- Percent of Cases with Late Stage : 74.1
Louisiana3
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.3 to 10.4 and 302 average annual cases over 2016-2020.
- CI*Rank⋔ : 1 (1, 11)
- Percent of Cases with Late Stage : 77.5
Maine6
- Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.3 to 8.8 and 90 average annual cases over 2016-2020.
- CI*Rank⋔ : 34 (9, 46)
- Percent of Cases with Late Stage : 67.2
Maryland6
- Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.3 to 9.1 and 358 average annual cases over 2016-2020.
- CI*Rank⋔ : 21 (7, 32)
- Percent of Cases with Late Stage : 71.8
Massachusetts3
- Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.3 and 434 average annual cases over 2016-2020.
- CI*Rank⋔ : 14 (6, 28)
- Percent of Cases with Late Stage : 73.4
Michigan6
- Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.6 to 9.2 and 633 average annual cases over 2016-2020.
- CI*Rank⋔ : 15 (7, 27)
- Percent of Cases with Late Stage : 73.1
Minnesota6
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.8 to 8.6 and 305 average annual cases over 2016-2020.
- CI*Rank⋔ : 28 (15, 40)
- Percent of Cases with Late Stage : 66.2
Mississippi6
- Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.4 to 9.5 and 183 average annual cases over 2016-2020.
- CI*Rank⋔ : 13 (2, 33)
- Percent of Cases with Late Stage : 73.8
Missouri6
- Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.8 to 8.5 and 352 average annual cases over 2016-2020.
- CI*Rank⋔ : 30 (19, 41)
- Percent of Cases with Late Stage : 72.2
Montana6
- Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.0 to 8.9 and 59 average annual cases over 2016-2020.
- CI*Rank⋔ : 35 (8, 48)
- Percent of Cases with Late Stage : 73.0
Nebraska6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.1 to 8.6 and 98 average annual cases over 2016-2020.
- CI*Rank⋔ : 36 (13, 47)
- Percent of Cases with Late Stage : 69.9
New Hampshire6
- Rate : The incidence rate is 8.7 with a 95% confidence interval from 7.8 to 9.6 and 86 average annual cases over 2016-2020.
- CI*Rank⋔ : 22 (2, 42)
- Percent of Cases with Late Stage : 70.4
New Jersey3
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.5 to 10.2 and 623 average annual cases over 2016-2020.
- CI*Rank⋔ : 3 (1, 9)
- Percent of Cases with Late Stage : 73.7
New Mexico3
- Rate : The incidence rate is 6.0 with a 95% confidence interval from 5.5 to 6.6 and 89 average annual cases over 2016-2020.
- CI*Rank⋔ : 49 (46, 49)
- Percent of Cases with Late Stage : 60.8
New York3
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.6 to 10.0 and 1,368 average annual cases over 2016-2020.
- CI*Rank⋔ : 4 (1, 8)
- Percent of Cases with Late Stage : 76.3
North Carolina6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.6 to 9.3 and 646 average annual cases over 2016-2020.
- CI*Rank⋔ : 12 (6, 26)
- Percent of Cases with Late Stage : 75.8
North Dakota6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 6.6 to 9.1 and 37 average annual cases over 2016-2020.
- CI*Rank⋔ : 38 (6, 49)
- Percent of Cases with Late Stage : 73.8
Ohio6
- Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.2 to 8.7 and 706 average annual cases over 2016-2020.
- CI*Rank⋔ : 27 (15, 34)
- Percent of Cases with Late Stage : 70.6
Oklahoma6
- Rate : The incidence rate is 7.4 with a 95% confidence interval from 6.9 to 7.9 and 193 average annual cases over 2016-2020.
- CI*Rank⋔ : 43 (30, 48)
- Percent of Cases with Late Stage : 69.1
Oregon6
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.7 to 8.7 and 240 average annual cases over 2016-2020.
- CI*Rank⋔ : 29 (14, 42)
- Percent of Cases with Late Stage : 71.4
Pennsylvania6
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.9 and 937 average annual cases over 2016-2020.
- CI*Rank⋔ : 6 (1, 11)
- Percent of Cases with Late Stage : 74.3
Puerto Rico6
- Rate : The incidence rate is 4.3 with a 95% confidence interval from 3.9 to 4.7 and 103 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 58.9
Rhode Island6
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 7.9 to 9.9 and 68 average annual cases over 2016-2020.
- CI*Rank⋔ : 19 (1, 43)
- Percent of Cases with Late Stage : 75.8
South Carolina6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.2 to 9.1 and 317 average annual cases over 2016-2020.
- CI*Rank⋔ : 23 (8, 35)
- Percent of Cases with Late Stage : 73.3
South Dakota6
- Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.0 to 10.4 and 52 average annual cases over 2016-2020.
- CI*Rank⋔ : 8 (1, 43)
- Percent of Cases with Late Stage : 77.4
Tennessee6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.3 to 8.1 and 357 average annual cases over 2016-2020.
- CI*Rank⋔ : 40 (28, 45)
- Percent of Cases with Late Stage : 68.5
Texas3
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.5 to 7.9 and 1,213 average annual cases over 2016-2020.
- CI*Rank⋔ : 41 (33, 44)
- Percent of Cases with Late Stage : 67.8
Utah3
- Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.2 to 7.5 and 100 average annual cases over 2016-2020.
- CI*Rank⋔ : 47 (37, 49)
- Percent of Cases with Late Stage : 71.3
Vermont6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 7.8 to 10.3 and 43 average annual cases over 2016-2020.
- CI*Rank⋔ : 11 (1, 44)
- Percent of Cases with Late Stage : 73.4
Virginia6
- Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.3 to 7.9 and 431 average annual cases over 2016-2020.
- CI*Rank⋔ : 42 (31, 46)
- Percent of Cases with Late Stage : 68.1
Washington5
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.5 to 9.2 and 427 average annual cases over 2016-2020.
- CI*Rank⋔ : 16 (6, 29)
- Percent of Cases with Late Stage : 75.6
West Virginia6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.3 to 9.7 and 126 average annual cases over 2016-2020.
- CI*Rank⋔ : 10 (1, 36)
- Percent of Cases with Late Stage : 76.2
Wisconsin6
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.4 to 9.2 and 361 average annual cases over 2016-2020.
- CI*Rank⋔ : 20 (6, 31)
- Percent of Cases with Late Stage : 73.8
Wyoming6
- Rate : The incidence rate is 6.7 with a 95% confidence interval from 5.6 to 8.1 and 25 average annual cases over 2016-2020.
- CI*Rank⋔ : 48 (19, 49)
- Percent of Cases with Late Stage : 75.1
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 09/27/2023 6:46 am.
State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
3 Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.